source

Global Healthcare Crisis: Legacy Systems Continue to Cause Pain for IT Decision Makers

Yet, 97% of IT decision makers report that their organization has legacy technology June 10, 2025 03:00 ET  | Source:…

9 months ago

Lyell Immunopharma Strengthens Clinical and Commercial Capabilities with Key Board and Executive Appointments

June 09, 2025 16:05 ET  | Source: Lyell Immunopharma, Inc Mark J. Bachleda, PharmD, MBA appointed as independent member of…

9 months ago

Sana Biotechnology Announces Invited Oral Presentation at the 85th Annual American Diabetes Association Scientific Sessions

Presentation to highlight updated six-month clinical results of a hypoimmune-modified primary pancreatic islet cell therapy for patients with type 1…

9 months ago

YXT.com’s AI Learning Platform Deployed by Siemens for Digital Workforce Transformation

June 09, 2025 06:00 ET  | Source: YXT.COM GROUP HOLDING LIMITED SUZHOU, China, June 09, 2025 (GLOBE NEWSWIRE) -- YXT.com…

9 months ago

Red Cat Supports Executive Orders to Strengthen U.S. Drone Manufacturing and National Security

June 09, 2025 06:00 ET  | Source: Red Cat Holdings, Inc. SAN JUAN, Puerto Rico, June 09, 2025 (GLOBE NEWSWIRE)…

9 months ago

Venus Concept Announces Up To $3.45 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

$1.15 million upfront with up to an additional $2.3 million of potential aggregate gross proceeds upon the exercise in full…

9 months ago

Replimune Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

June 06, 2025 16:01 ET  | Source: Replimune Group Inc WOBURN, Mass., June 06, 2025 (GLOBE NEWSWIRE) -- Replimune Group,…

9 months ago

Keros Therapeutics Announces Participation at Goldman Sachs 46th Annual Global Healthcare Conference

June 06, 2025 16:01 ET  | Source: Keros Therapeutics, Inc. LEXINGTON, Mass., June 06, 2025 (GLOBE NEWSWIRE) -- Keros Therapeutics,…

9 months ago

Zealand Pharma increases its share capital as a result of the exercise of employee warrants

June 06, 2025 16:00 ET  | Source: Zealand Pharma Company announcement – No. 14 / 2025 Zealand Pharma increases its…

9 months ago

RESTEM to Present Phase 2/3 IIMPACT Trial Design in Idiopathic Inflammatory Myopathy at EULAR 2025 Congress

June 06, 2025 16:07 ET  | Source: Restem MIAMI, June 06, 2025 (GLOBE NEWSWIRE) -- RESTEM – a clinical-stage biotechnology…

9 months ago